David J. Matlin
David J. Matlin's purchase track record
How the stock did after each of David J. Matlin's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/13/2026 | CLNN | $217K | +31.0% | +21.4% | +8.3% |
| 9/30/2024 | CLNN | $438K | +8.9% | -32.9% | -2.6% |
| 11/10/2023 | CLNN | $103K | -4.4% | -13.3% | +18.3% |
| 6/16/2023 | CLNN | $1.20M | -36.5% | -50.6% | +7.0% |
| 11/2/2022 | CLNN | $2.90M | +49.0% | -10.6% | +8.8% |
| 6/14/2022 | CLNN | $630K | +2.9% | -61.9% | +7.6% |
| 6/6/2022 | CLNN | $299K | -0.7% | -60.1% | -3.0% |
| 5/27/2022 | CLNN | $104K | +40.8% | -55.3% | -3.2% |
| 5/16/2022 | CLNN | $400K | +70.6% | -52.8% | -1.3% |
| 4/20/2022 | CLNN | $400K | +50.2% | -52.5% | -17.1% |
| 3/28/2022 | CLNN | $59K | -3.1% | -8.8% | -20.1% |
| 3/18/2022 | CLNN | $276K | -16.0% | +5.0% | -13.2% |
| 2/1/2022 | CLNN | $300K | -9.8% | +19.3% | -10.0% |
| 12/8/2021 | CLNN | $298K | -37.6% | -30.9% | -12.4% |
| 11/12/2021 | CLNN | $245K | -50.6% | -61.5% | -14.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
TriSalus Stock Rises After FDA Clears TriNav Advance. TriSalus Life Sciences shares climbed 15.6% following FDA clearance for its TriNav Advance product. This regulatory approval marks a significant milestone for the company's pipeline. The stock is currently testing key support levels after the recent price movement.
Transaction History
| CLNN | ▲ Buy | Grant | 434,451 | $1.4M | 9/16/2026 | View on chart |
| TLSI | ▲ Buy | Grant | 28,201 | $0 | 5/14/2026 | View on chart |
| TLSI | ▲ Buy | Grant | 23,065 | $0 | 5/14/2026 | View on chart |
| CLNN | ▲ Buy | Open Market | 33,333 | $217K | 1/13/2026 | View on chart |
| TLSI | ▼ Sell | Other | 330,000 | $0 | 7/31/2025 | View on chart |
| TLSI | ▲ Buy | Grant | 10,040 | $0 | 1/2/2025 | View on chart |
| CLNN | ▲ Buy | Open Market | 92,307 | $438K | 9/30/2024 | View on chart |
| CLNN | ▲ Buy | Open Market | 250,002 | $103K | 11/10/2023 | View on chart |
| TLSI | ▼ Sell | Other | 931,904 | — | 8/10/2023 | View on chart |
| CLNN | ▲ Buy | Open Market | 1,500,000 | $1.2M | 6/16/2023 | View on chart |
| CLNN | ▲ Buy | Open Market | 2,871,287 | $2.9M | 11/2/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 74,610 | $187K | 6/17/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 75,000 | $188K | 6/16/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 45,000 | $120K | 6/15/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 51,011 | $136K | 6/14/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 55,000 | $168K | 6/13/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 50,670 | $130K | 6/6/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 10,000 | $25K | 6/3/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 35,000 | $79K | 5/27/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 181,818 | $400K | 5/16/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 132,891 | $400K | 4/20/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 8,648 | $28K | 3/29/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 10,000 | $31K | 3/28/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 20,000 | $60K | 3/24/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 20,000 | $59K | 3/23/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 35,000 | $102K | 3/21/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 20,000 | $56K | 3/18/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 101,352 | $300K | 2/1/2022 | View on chart |
| CLNN | ▲ Buy | Open Market | 15,000 | $73K | 12/10/2021 | View on chart |
| CLNN | ▲ Buy | Open Market | 40,000 | $200K | 12/9/2021 | View on chart |
| CLNN | ▲ Buy | Open Market | 5,000 | $25K | 12/8/2021 | View on chart |
| CLNN | ▼ Sell | Other | 12,500 | $125 | 12/6/2021 | View on chart |
| CLNN | ▼ Sell | Other | 50,000 | $500 | 12/6/2021 | View on chart |
| CLNN | ▲ Buy | Open Market | 20,000 | $105K | 11/16/2021 | View on chart |
| CLNN | ▲ Buy | Open Market | 15,000 | $86K | 11/15/2021 | View on chart |
| CLNN | ▲ Buy | Open Market | 10,000 | $54K | 11/12/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Clene to Present at Investor Conferences
Clene Inc. announced it will present at several upcoming investor conferences. The company will use the events to share updates on its operations and strategy. The announcement is a routine corporate event that may increase visibility among investors.
Clene to Present at Investor Conferences. Clene Inc. announced it will present at several upcoming investor conferences. The company will use the events to share updates on its operations and strategy. The announcement is a routine corporate event that may increase visibility among investors.